PKM2 Is Required to Activate Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia

<div>mDCs were visualized identified by SEM: (a) the shape of typical round mDCs after PKM2 siRNA transfection (original magnification: 5000x); (b) a more matured mDC in the siRNA-control group (original magnification: 5000x).</div>

Oxidative Medicine and Cellular Longevity

fig2

Figure 2

Figure 2: PKM2 Is Required to Activate Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia 